U.S. Medical Tubing Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

U.S. Medical Tubing Market Trends and Insights

Rising Minimally Invasive and Catheter-Based Procedure Volumes

The United States medical tubing market is experiencing significant growth, driven by the transition from open surgeries to catheter-based interventions. Transcatheter aortic valve replacements have exceeded 100,000 annual procedures, while mitral transcatheter edge-to-edge repairs have surpassed 15,000 cases annually.^{[1]Contemporary Operator Procedural Volumes and Outcomes for TAVR and MTEER in the US,” PubMed Central, pmc.ncbi.nlm.nih.gov} This increase in structural heart procedures is reshaping demand, as modern catheter systems require advanced designs with tighter tolerances, thinner walls, and layered shaft constructions. These advancements are driving demand for premium catheter liners, reinforced shafts, and multi-material tubing. Additionally, the expansion of ambulatory surgical centers is diversifying procurement channels, creating opportunities for more suppliers to enter the market.

Higher Single-Use Tubing Demand from Infection Control and Care Settings

Rising infection control requirements across inpatient, outpatient, and procedural settings are boosting demand for single-use tubing. Pre-sterilized and disposable tubing assemblies align with risk reduction protocols and reduce the burden of reprocessing. This shift increases replacement frequency, accelerating the refresh cycle for administration sets, pump tubing, and sterile fluid-transfer assemblies. The FDA's updated quality framework further supports this trend by emphasizing risk management and process control for device manufacturers.

Aging Chronic-Care Population Lifting Dialysis, Cardiovascular, and Home Care Tubing Demand

The growing chronic disease burden in the United States is driving demand for medical tubing in dialysis, cardiovascular care, and home-based therapies. Each setting has unique material and dimensional requirements, ensuring broad product demand. Dialysis tubing requires specific performance profiles, cardiovascular applications have distinct needs, and home infusion therapy relies on pump tubing, IV sets, and enteral feeding assemblies. This ongoing utilization tied to continuous care ensures steady demand. The National Home Infusion Association's March 2026 report highlights home infusion's growing impact across outpatient, home, and ambulatory care channels, supporting tubing volume growth through the forecast period.^{[2]NHIA Releases Infusion Industry Trends Report,” National Home Infusion Association, nhia.org}

Home Infusion and Ambulatory Care Migration Expanding Pump and Fluid-Transfer Tubing Demand

The shift of infusion therapy to ambulatory centers and home settings is reshaping purchasing dynamics in the United States medical tubing market. As care moves away from hospital outpatient departments, purchasing decisions now emphasize flexibility, service levels, and qualification support. This shift creates opportunities for specialized tubing manufacturers capable of catering to smaller lot sizes and faster response times. Additionally, payer-driven transitions of oncology, immunology, and anti-infective infusions to cost-effective care sites are expanding demand for pump tubing and single-use fluid-transfer products. The National Home Infusion Association's 2026 industry update underscores home infusion's growing role in the infusion care model.

FDA Biocompatibility and Extractables Characterization Burden

In the U.S. medical tubing market, biocompatibility and extractables assessments pose significant challenges for product developers. The FDA's alignment with ISO 10993 standards has intensified the toxicological reviews and material assessments for tubing, especially those used in drug delivery, dialysis, and infusion.^{[3]“PFAS in Medical Devices,” U.S. Food and Drug Administration, fda.gov} New polymer designs, lacking the extensive usage history of established PVC or silicone systems, face heightened scrutiny. This not only extends development timelines but also hampers the transition from prototype to commercial production. Furthermore, the Federal Register's rulemaking on QMSR introduces additional design-control and documentation mandates, further delaying the entry of new tubing designs into regulated production.

Volatility in Medical-Grade Silicone, PVC, Fluoropolymer, and Specialty Material Pricing

The U.S. medical tubing industry is feeling the pinch of material cost fluctuations, impacting both profit margins and strategic planning. This pricing uncertainty is particularly challenging as tubing manufacturers often finalize commitments to customer programs before fully grasping the trajectory of feedstock costs. The challenge spans multiple material families: silicone, PVC, fluoropolymers, and various specialty polymers can all experience supply disruptions or price shifts at different times. Notably, fluoropolymer sourcing has become increasingly delicate, with supplier concentration tightening due to the exit of prominent producers. 

Segment Analysis

By Material: Specialty Polymers Lead the Innovation Cycle

Specialty polymers are the fastest-growing material segment in the United States medical tubing market, with a projected CAGR of 10.18% from 2026 to 2031. Advanced catheter and drug delivery designs increasingly require properties that commodity materials cannot consistently provide. Materials like PEBA, PEEK, and thermoplastic polyurethane are preferred for tighter dimensional control, enhanced kink resistance, and superior chemical stability. This shift is most significant in vascular, neurovascular, and minimally invasive applications, where tubing performance directly impacts device handling.

In 2025, plastic tubing held a 38.12% share of the United States medical tubing market, reflecting its strong presence in high-volume disposable and IV administration applications. PVC remains popular due to its cost efficiency, processability, and extensive biocompatibility documentation. Rubber tubing, led by silicone and latex-based formats, is essential in peristaltic pump systems, respiratory circuits, and long-duration drainage applications. 

By Structure: Single-lumen Dominance Supports Mass-Volume Production

Single-lumen tubing accounted for 40.25% of the United States medical tubing market in 2025, making it the largest structural format. Its simplicity suits bulk applications like IV sets and catheter shafts, ensuring production efficiency and compatibility with conventional extrusion platforms. This structure remains integral to fluid management products widely used in hospitals and ambulatory settings. Single-lumen tubing continues to dominate due to its broad demand and recurring replacement volumes.

Micro-extruded and microbore tubing is the fastest-growing structural segment, with a 10.75% CAGR from 2026 to 2031. This growth is driven by catheter miniaturization in neurovascular access and robotic-assisted systems, where smaller profiles enhance navigation and outcomes. Multi-lumen and co-extruded tubing are also gaining traction as advanced catheter shafts integrate multiple functionalities. Zeus highlighted this trend in January 2026 with the launch of the PFX platform and PFX Flex Sub-Lite-Wall, designed for modern catheter construction.

By Application: Drug Delivery Leads, Drainage Tubing Accelerates

Drug delivery systems represented 29.31% of the United States medical tubing market in 2025, driven by IV therapy, infusion pump cassettes, and specialty delivery catheters. These applications demand biocompatibility, stable extractables profiles, and precise dimensional control. The growing home infusion channel is expanding the demand base as more patients receive biologics and specialty infusions outside hospitals. This trend broadens the market footprint without shifting demand away from traditional care settings.

Suction, smoke evacuation, and drainage tubing is the fastest-growing application segment, with a 9.45% CAGR from 2026 to 2031. The rise in minimally invasive surgeries and robotic-assisted procedures is increasing the need for controlled smoke evacuation and fluid management. Biopharmaceutical laboratory tubing, though smaller in volume, remains a high-value niche due to single-use bioprocessing infrastructure and stricter manufacturing standards. Other segments like catheters, dialysis tubing, and respiratory systems continue to diversify the market with distinct material and dimensional needs.

By End User: Hospital Networks Consolidate Procurement, Home Care Accelerates

Hospitals and integrated delivery networks held 52.68% of the United States medical tubing market share in 2025, reflecting their dominance in high-complexity procedures and disposable consumption. Centralized purchasing through group structures ensures volume visibility, even amid competitive pricing. Hospital demand anchors tubing programs tied to IV administration, catheterization, and procedural care, maintaining its leading position in the market.

Home care is the fastest-growing end-user segment, with a 9.34% CAGR from 2026 to 2031. The shift of infusion therapy, dialysis, and enteral feeding into home settings is driving recurring tubing use in cost-effective care environments. Ambulatory surgical centers are also expanding as more procedures move out of hospital outpatient departments. Physician offices and specialty clinics see steady growth, while laboratories and biopharmaceutical facilities remain smaller but high-value segments due to specialized tubing needs.

By Manufacturing Process: Micro-extrusion Captures High-Precision Segment Growth

Micro-extrusion is the fastest-growing manufacturing process in the United States medical tubing market, with a 10.51% CAGR from 2026 to 2031. Rising demand for precise internal diameters and wall thicknesses in catheter programs drives this growth. Manufacturers with validated micro-extrusion operations and expertise in materials like PEBA and PEEK gain a competitive edge, ensuring pricing resilience and market leadership.

Single-screw extrusion accounted for 48.05% of production volume in 2025, highlighting its role in large-scale output for PVC and polyolefin programs. Twin-screw extrusion is gaining importance in specialty compounding, ensuring better mixing of additives for high-performance formulations. The industry is evolving with a layered manufacturing mix, where legacy platforms and high-precision technologies coexist to meet diverse market demands.

Geography Analysis

The United States medical tubing market operates nationally, but demand, innovation, and production are concentrated in specific regional hubs. The Northeast, particularly the Boston, New York, and Philadelphia corridor, combines academic medical centers, integrated delivery networks, and a strong biopharma presence. This drives demand for drug delivery tubing, catheter components, and laboratory processing tubing in clinical and manufacturing settings. 

The South and Southeast are emerging as significant manufacturing hubs and fast-growing procedural markets. Zeus, a leading catheter tubing and liner specialist, is headquartered in Orangeburg, South Carolina, with multiple facilities supporting catheter OEMs nationwide. RAUMEDIC’s operations in Mills River, North Carolina, enhance the region's profile as a cleanroom-based production hub for customized tubing and molded components. 

The Midwest remains vital due to its concentration of medical device OEMs and established catheter assembly and extrusion capabilities. Minneapolis exemplifies this, hosting major device manufacturers whose R&D programs sustain demand for precision tubing and assembly services. Spectrum Plastics Group, now part of DuPont, has expanded its Minneapolis operations with catheter assembly capabilities, reinforcing the region's role in high-value tubing programs.